Pleural drainage and pleurodesis: implementation of guidelines in four hospitals

被引:32
作者
Burgers, J. A. [1 ]
Kunst, P. W. A. [2 ]
Koolen, M. G. J. [3 ]
Willems, L. N. A. [4 ]
Burgers, J. S. [5 ]
van den Heuvel, M.
机构
[1] Netherlands Canc Inst, Dept Thorac Oncol, NL-1066 CX Amsterdam, Netherlands
[2] Free Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[4] Leiden Univ, Med Ctr, Leiden, Netherlands
[5] Dutch Inst Healthcare Improvement CBO, Utrecht, Netherlands
关键词
Guidelines; malignant pleurisy; pleurodesis; predictive factors; talc;
D O I
10.1183/09031936.00165607
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The aim of the present study was to evaluate the implementation of the 2003 Dutch guideline on the diagnosis and treatment of malignant pleural effusions, and the potential effect of the implementation on the clinical outcome of pleurodesis. All patients with malignant pleural effusion who had a pleural drain placed with the intention of performing pleurodesis were registered prospectively in four centres. Details of the procedure and fluid recurrence and survival data were noted. Patients with a proven malignancy (n=100) were entered into the registration database. Diagnostic guideline recommendations were followed in 60-70% of the patients. Surprisingly, pleurodesis was performed in only 75% of the patients, mainly due to the presence of a trapped lung. All pleurodeses were performed using talc, according to the guideline. Follow-up revealed fluid recurrence in 27 (36%) patients after a mean follow-up of 17 days (range 2-285 days); 14 patients with successful pleurodesis died with a median survival of 61 days (range 13-174 days). Systemic treatment following pleurodesis and good apposition of the pleural surfaces during drainage were good prognostic factors. Despite reasonable-to-good adherence to the guideline, the number of successful pleurodeses was low. Better predictors of a good pleurodesis outcome are needed.
引用
收藏
页码:1321 / 1327
页数:7
相关论文
共 28 条
[1]  
[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002916.PUB2
[2]   Management of malignant pleural effusions [J].
Antony, VB ;
Loddenkemper, R ;
Astoul, P ;
Boutin, C ;
Goldstraw, P ;
Hott, J ;
Panadero, FR ;
Sahn, SA .
EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (02) :402-419
[3]  
ANTUNES G, 2003, THORAX S2, V58, P29, DOI DOI 10.1136/THORAX.58.SUPPL_2.II29
[4]   Predicting survival in patients with recurrent symptomatic malignant pleural effusions - An assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease [J].
Burrows, CM ;
Mathews, C ;
Colt, HG .
CHEST, 2000, 117 (01) :73-78
[5]   Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma [J].
Crnjac, A ;
Sok, M ;
Kamenik, M .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2004, 26 (02) :432-436
[6]  
DAVIES RJ, 2003, THORAX S2, V58, P1
[7]   Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion [J].
Dresler, CM ;
Olak, J ;
Herndon, JE ;
Richards, WG ;
Scalzetti, E ;
Fleishman, SB ;
Kernstine, KH ;
Demmy, T ;
Jablons, DM ;
Kohman, L ;
Daniel, TM ;
Haasler, GB ;
Sugarbaker, DJ .
CHEST, 2005, 127 (03) :909-915
[8]  
*DUTCH I HEALTHC I, DEV EV BAS CLIN PRAC
[9]   Efficacy of short-term versus long-term chest tube drainage following talc slurry pleurodesis in patients with malignant pleural effusions: A randomised trial [J].
Goodman, Anna ;
Davies, Christopher W. H. .
LUNG CANCER, 2006, 54 (01) :51-55
[10]  
Grimshaw JM., 2001, MED CARE S2, V39, pIi2, DOI DOI 10.1097/00005650-200108002-00002